1 year return (CAGR)
-27.70%
Equasens S. A. Exchange (PA, EUR)
EQS.PA
29.10
-0.40 (-1.36%)
HealthcareHealth Information Services
Loading...
3 year return (CAGR)
-23.26%
5 year return (CAGR)
-21.35%
10 year return (CAGR)
-1.76%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
437.38M
Price/Sales
0.93
Ent value
607.28M
Price/Book
1.68
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
75.19%
Trailing P/E
5.65
PEG
-
Forward P/E
8.84
EPS growth
4.91%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 29.55 |
| Daily high | 29.75 |
| Daily low | 29.00 |
| Daily Volume | 27K |
| All-time high | 122.60 |
| 1y analyst estimate | 54.67 |
| Beta | 0.56 |
| EPS (TTM) | 4.90 |
| Dividend per share | 0.00 |
| Ex-div date | 1 Jul 2026 |
| Next earnings date | 30 Mar 2026 |
Downside potential
Loading...
Downside potential data
| EQS.PA | S&P500 | |
| Current price drop from All-time high | -76.26% | -1.06% |
| Highest price drop | -76.43% | -56.47% |
| Date of highest drop | 24 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -20.15% | -10.67% |
| Avg time to new high | 27 days | 12 days |
| Max time to new high | 1465 days | 1805 days |
News
Villers-lès-Nancy, 30 March 2026 - 08:00 (CEST) PRESS RELEASE 2025 annual resultsEquasens reports a solid performanceacross all financial indicators FY 2025 revenue of €236.5 million (+9.1%): continue...
March 30, 2026
Strong growth in maintenance and subscriptions revenue (+8.4% to €55.7 million), including solid organic growth (+4.7%) in H1 2026 Positive momentum in the French Pharmacy business, driven in particul...
July 30, 2026
PRESS RELEASE H1 2026 results: well-managed growth and improved profitability H1 2026 revenue of €124.5m (+7.3%): growth driven by the Erevo acquisition and the integration of Novaprove and the DIS bu...
September 28, 2026
Equasens Activates the Business Continuity Plan for its subsidiary ASCA in Chessy (France,77) Villers-lès-Nancy, September 22, 2026, 5:45 p.m. CEST – Equasens (ISIN: FR0012882389 – Ticker: EQS), a lea...
September 22, 2026
As European markets navigate the challenges of geopolitical tensions and inflationary pressures, investors continue to seek stability and growth through dividend stocks. In such a climate, selecting s...
May 19, 2026
Villers-lès-Nancy, 29 April 2026 - 6:00 PM (CEST) PRESS RELEASE Solid Q1 2026 performance: revenue of €61.4 million(+7.7% reported) Continued momentum in the PHARMAGEST and AXIGATE LINK divisionsSucce...
April 29, 2026